Genelux Corporation(GNLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GNLX Genelux Corporation

Post-Market Trading 05-28 18:26:57 EDT

2.79

+0.17

+6.49%

盘后2.79

+0.00+0.00%

17:25 EDT

High2.86	Low2.56	Vol892.30K
Open2.70	D1 Closing2.62	Amplitude11.64%
Mkt Cap93.29M	Tradable Cap71.07M	Total Shares33.44M
T/O2.43M	T/O Rate3.50%	Tradable Shares25.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GNLX","market":"US","secType":"STK","nameCN":"Genelux Corporation","latestPrice":2.79,"timestamp":1716926400000,"preClose":2.62,"halted":0,"volume":892304,"hourTrading":{"tag":"盘后","latestPrice":2.7901,"preClose":2.79,"latestTime":"17:25 EDT","volume":2364,"amount":6556.58946,"timestamp":1716931541414},"delay":0,"floatShares":25474388,"shares":33438407,"eps":-0.982291,"marketStatus":"Post-Market Trading","change":0.17,"latestTime":"05-28 18:26:57 EDT","open":2.7,"high":2.86,"low":2.555,"amount":2430318.2573152,"amplitude":0.116412,"askPrice":2.95,"askSize":5,"bidPrice":2.67,"bidSize":1105,"shortable":0,"etf":0,"ttmEps":-0.982291,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1716940800000},"marketStatusCode":4,"adr":0,"listingDate":1674709200000,"exchange":"NASDAQ","adjPreClose":2.62,"preHourTrading":{"tag":"盘前","latestPrice":2.6901,"preClose":2.62,"latestTime":"09:28 EDT","volume":4791,"amount":12888.775987800002,"timestamp":1716902880272},"postHourTrading":{"tag":"盘后","latestPrice":2.7901,"preClose":2.79,"latestTime":"17:25 EDT","volume":2364,"amount":6556.58946,"timestamp":1716931541414},"volumeRatio":0.909307},"requestUrl":"/m/hq/s/GNLX","defaultTab":"news","newsList":[{"id":"2437030521","title":"Dow Surges 50 Points; US Durable Goods Orders Increase In April","url":"https://stock-news.laohu8.com/highlight/detail?id=2437030521","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2437030521?lang=en_us&edition=fundamental","pubTime":"2024-05-24 21:43","pubTimestamp":1716558195,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/39007702/dow-surges-50-points-us-durable-goods-orders-increase-in-april","is_publish_highlight":false,"gpt_icon":0},{"id":"2437196055","title":"Genelux 6.875M share Spot Secondary priced at $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2437196055","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2437196055?lang=en_us&edition=fundamental","pubTime":"2024-05-24 21:02","pubTimestamp":1716555761,"startTime":"0","endTime":"0","summary":"Genelux  stock plummets 24% premarket on pricing of an underwritten offering of 6.88M shares and accompanying warrants to purchase 6.88M shares of its common stock at a combined offering price of $4/share and accompanying warrant. Each warrant will have an exercise price of $5.25/share, will be immediately exercisable following the closing of the offering.  Gross proceeds to Genelux from the offering are expected to be ~$27.5M and the net proceeds are expected to provide working capital into the Q1 2026 for general corporate purposes. The offering is expected to close on or about May 29, 2024, GNLX -24.1% premarket to $3.49.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4110226-genelux-6875m-share-spot-secondary-priced-at-4","is_publish_highlight":false,"gpt_icon":0},{"id":"2437034598","title":"Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2437034598","media":"MT Newswires Live","top":-1,"share":"https://ttm.financial/m/news/2437034598?lang=en_us&edition=fundamental","pubTime":"2024-05-24 20:58","pubTimestamp":1716555496,"startTime":"0","endTime":"0","summary":"Genelux  said Friday it has priced an underwritten public offering of about 6.9 million shares and warrants to buy the same number of shares at a combined price of $4 per share, for expected gross proceeds of $27.5 million.The company said the accompanying warrants will have an exercise price of $5.25 apiece, immediately exercisable following closing of the offer. The warrants to purchase shares will expire five years from the date of issuance, the company said.Underwriters have been granted a 30-day option to purchase about 1 million additional shares and accompanying warrants to purchase 1 million shares of its common stock to cover over-allotments, if any.Net proceeds will be used to provide working capital into Q1 2026 for general corporate purposes, including clinical development of Olvi-Ve, Genelux said.The offering is expected to close Wednesday, subject to customary closing conditions.Shares of Genelux were down nearly 25% in recent Friday premarket activity.Price: 3.4701, Chan","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"gpt_icon":0},{"id":"2437397690","title":"BRIEF-Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2437397690","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2437397690?lang=en_us&edition=fundamental","pubTime":"2024-05-24 20:31","pubTimestamp":1716553861,"startTime":"0","endTime":"0","summary":"May 24  - Genelux Corp   :   * GENELUX CORPORATION ANNOUNCES PRICING OF APPROXIMATELY $27.5 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK AND ACCOMPANYING WARRANTS   * GENELUX WARRANTS EXERCISABLE AT $5.25 POST-OFFERINGSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2437471284","title":"Genelux Shares Sink After Underwritten Public Offering Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=2437471284","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2437471284?lang=en_us&edition=fundamental","pubTime":"2024-05-24 05:49","pubTimestamp":1716500940,"startTime":"0","endTime":"0","summary":"Shares of Genelux fell by a quarter after the company launched an underwritten public offering of common stock and accompanying warrants.The stock was down 25%, at $3.46, in postmarket trading. Shares closed the market down 67% year-to-date on Thursday.The late-stage clinical-stage immuno-oncology company said after the closing bell that the offering is being made in connection with a previously filed shelf registration. Terms of the offering weren't disclosed in the company's latest filing.Genelux said it expects to grant underwriters a 30-day option to buy up to an additional 15% of shares that are sold in connection with the offering.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2437603720","title":"Genelux Launches Securities Offering; Shares Fall After-Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2437603720","media":"MT Newswires Live","top":-1,"share":"https://ttm.financial/m/news/2437603720?lang=en_us&edition=fundamental","pubTime":"2024-05-24 05:24","pubTimestamp":1716499474,"startTime":"0","endTime":"0","summary":"Genelux  said late Thursday it launched an underwritten public offering of an undisclosed amount of its shares and accompanying warrants, with Guggenheim Securities as the book-runner.The company expects to grant a 30-day option to the underwriters that covers up to an additional 15% of the number of shares sold in the offering, it said.Genelux shares were down about 24% in after-hours activity.Price: 3.4800, Change: -1.12, Percent Change: -24.35","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"gpt_icon":0},{"id":"2437460714","title":"Genelux announces proposed public offering of common stock and warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2437460714","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2437460714?lang=en_us&edition=fundamental","pubTime":"2024-05-24 04:16","pubTimestamp":1716495377,"startTime":"0","endTime":"0","summary":"Genelux (NASDAQ:GNLX) on Thursday announced that it has commenced an underwritten public offering of its common stock and accompanying warrants.\nAll shares of common stock and accompanying warrants are being offered by Genelux. Source: Press Release","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4110039-genelux-announces-proposed-public-offering-of-common-stock-and-warrants","is_publish_highlight":false,"gpt_icon":0},{"id":"2437971846","title":"Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2437971846","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2437971846?lang=en_us&edition=fundamental","pubTime":"2024-05-24 04:01","pubTimestamp":1716494460,"startTime":"0","endTime":"0","summary":"WESTLAKE VILLAGE, Calif., May  23, 2024  (GLOBE NEWSWIRE) -- Genelux Corporation (Genelux) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced an under","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/23/2887625/0/en/Genelux-Corporation-Announces-Proposed-Public-Offering-of-Common-Stock-and-Warrants.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2437763789","title":"Jaguar Health, Altamira Therapeutics, Erasca among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2437763789","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2437763789?lang=en_us&edition=fundamental","pubTime":"2024-05-23 22:04","pubTimestamp":1716473077,"startTime":"0","endTime":"0","summary":"Gainers: Altamira Therapeutics  +42%. Bicycle Therapeutics ADR BCYC +19%. Genelux  +13%. Erasca  +11%. HeartBeam  +11%.  Losers: Akanda  -26%. Protagenic Therapeutics  -18%. Jaguar Health  -18%. Cytokinetics CYTK -18%. SILO Pharma  -4%.  S&P 500 Health Care Sector -0.42% to 1697.24. Health Care Equipment & Services -0.48% to 1952.1. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is -0.36% to 1399.5.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4109860-jaguar-health-altamira-therapeuticserasca-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2437675187","title":"NVIDIA, Dell Technologies, Super Micro Computer among premarket gainers' pack","url":"https://stock-news.laohu8.com/highlight/detail?id=2437675187","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2437675187?lang=en_us&edition=fundamental","pubTime":"2024-05-23 20:48","pubTimestamp":1716468484,"startTime":"0","endTime":"0","summary":"Greenwave Technology Solutions  +55% after eliminates all convertible debt. Ascent Solar Technologies  +49%. Bicycle Therapeutics  +14% after announces $555 million private placement equity financing. Geovax Labs  +10%. Borr Drilling BORR +10% on Q1 earnings release and raises dividend. Genelux  +9%.  CXApp  +7%. NVIDIA NVDA +7% gains as Q1 results, guidance top expectations; announces 10-1 split. Dell Technologies  +6% after Dell and Ericsson join forces to develop tailored network cloud infrastructure plans and advise communications service providers on their cloud transformation journeys. Maxeon Solar Technologies  +6%. GoodRx Holdings  +6%. DuPont de Nemours DD +6% after unveiling plans to split into three publicly traded companies, and appointing current CFO Lori Koch as its new CEO effective June 1. Pacific Biosciences of California  +5%. Super Micro Computer  +5% gains amid Nvidia earnings; BofA reiterates Buy. See the biggest morning stock movers.","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4109816-nvidia-dell-technologies-super-micro-computer-among-premarket-gainers-pack","is_publish_highlight":false,"gpt_icon":1},{"id":"2434702963","title":"Genelux Q1 2024 GAAP EPS $(0.29) Misses $(0.24) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2434702963","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2434702963?lang=en_us&edition=fundamental","pubTime":"2024-05-10 06:01","pubTimestamp":1715292097,"startTime":"0","endTime":"0","summary":"Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38748754/genelux-q1-2024-gaap-eps-0-29-misses-0-24-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2434304071","title":"Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2434304071","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2434304071?lang=en_us&edition=fundamental","pubTime":"2024-05-09 20:25","pubTimestamp":1715257500,"startTime":"0","endTime":"0","summary":"WESTLAKE VILLAGE, Calif., May  09, 2024  (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/09/2879242/0/en/Genelux-Corporation-Reports-First-Quarter-2024-Financial-Results-and-Provides-General-Business-Updates.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430096212","title":"Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2430096212","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2430096212?lang=en_us&edition=fundamental","pubTime":"2024-04-26 21:35","pubTimestamp":1714138506,"startTime":"0","endTime":"0","summary":"Genelux Corporation  has been on a downward spiral lately with significant selling pressure. After declining 48.4% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.The heavy selling of GNLX shares appears to be in the process of exhausti","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/aMCT_Lh5K9xNn9.QUdX03w--~B/aD01ODc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/aMCT_Lh5K9xNn9.QUdX03w--~B/aD01ODc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/17a4db66bb13bdabcbf848550a6ea15a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/down-48-37-4-weeks-133506649.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426198129","title":"Genelux Corp Unveils Strategic Corporate Outlook Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2426198129","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426198129?lang=en_us&edition=fundamental","pubTime":"2024-04-10 04:34","pubTimestamp":1712694889,"startTime":"0","endTime":"0","summary":"Genelux Corp. (GNLX) has issued an announcement. Genelux Corporation recently unveiled their corporate presentation, which may be employed in futur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genelux-corp-unveils-strategic-corporate-outlook-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genelux-corp-unveils-strategic-corporate-outlook-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2425561764","title":"After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2425561764","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2425561764?lang=en_us&edition=fundamental","pubTime":"2024-04-05 21:35","pubTimestamp":1712324106,"startTime":"0","endTime":"0","summary":"A downtrend has been apparent in Genelux Corporation  lately with too much selling pressure. The stock has declined 26.2% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.The heavy selling of GNLX shares appears to be in ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gUf3JPAiwp3PVjuDKftvaA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gUf3JPAiwp3PVjuDKftvaA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/plunging-26-21-4-weeks-133506255.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424864886","title":"Genelux (NASDAQ:GNLX) Price Target Lowered to $32.00 at HC Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2424864886","media":"Defense World","top":-1,"share":"https://ttm.financial/m/news/2424864886?lang=en_us&edition=fundamental","pubTime":"2024-04-03 15:31","pubTimestamp":1712129498,"startTime":"0","endTime":"0","summary":"Genelux (NASDAQ:GNLX) Price Target Lowered to $32.00 at HC Wainwright","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmRlZmVuc2V3b3JsZC5uZXQvMjAyNC8wNC8wMy9nZW5lbHV4LW5hc2RhcWdubHgtcHJpY2UtdGFyZ2V0LWxvd2VyZWQtdG8tMzItMDAtYXQtaGMtd2FpbndyaWdodC5odG1s0gEA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmRlZmVuc2V3b3JsZC5uZXQvMjAyNC8wNC8wMy9nZW5lbHV4LW5hc2RhcWdubHgtcHJpY2UtdGFyZ2V0LWxvd2VyZWQtdG8tMzItMDAtYXQtaGMtd2FpbndyaWdodC5odG1s0gEA?oc=5","is_publish_highlight":false,"gpt_icon":0},{"id":"2424869216","title":"U.S. RESEARCH ROUNDUP- Ally Financial, GE Vernova, Navient","url":"https://stock-news.laohu8.com/highlight/detail?id=2424869216","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2424869216?lang=en_us&edition=fundamental","pubTime":"2024-04-03 15:28","pubTimestamp":1712129335,"startTime":"0","endTime":"0","summary":"April 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ally Financial, GE Vernova and Navient on Wednesday.    HIGHLIGH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424092146","title":"Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2424092146","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2424092146?lang=en_us&edition=fundamental","pubTime":"2024-04-02 18:30","pubTimestamp":1712053815,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Genelux Corp. (GNLX – Research Report), Adicet Bio (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genelux-corp-gnlx-adicet-bio-acet-and-entera-bio-entx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genelux-corp-gnlx-adicet-bio-acet-and-entera-bio-entx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2424094125","title":"Genelux Corp. Unveils New Corporate Presentation for Future Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2424094125","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2424094125?lang=en_us&edition=fundamental","pubTime":"2024-04-02 18:13","pubTimestamp":1712052833,"startTime":"0","endTime":"0","summary":"The latest update is out from Genelux Corp. (GNLX). Genelux Corporation has released its latest corporate presentation, which will be used by manag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genelux-corp-unveils-new-corporate-presentation-for-future-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genelux-corp-unveils-new-corporate-presentation-for-future-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2424179472","title":"Genelux Q4 EPS $(0.25) Misses $(0.19) Estimate, Cash Balance of $23.2M","url":"https://stock-news.laohu8.com/highlight/detail?id=2424179472","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2424179472?lang=en_us&edition=fundamental","pubTime":"2024-04-01 19:02","pubTimestamp":1711969325,"startTime":"0","endTime":"0","summary":"Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by 31.58 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38018867/genelux-q4-eps-0-25-misses-0-19-estimate-cash-balance-of-23-2m","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genelux.com","stockEarnings":[{"period":"1week","weight":-0.2822},{"period":"1month","weight":-0.2406},{"period":"3month","weight":-0.6072},{"period":"6month","weight":-0.764},{"period":"1year","weight":-0.8944},{"period":"ytd","weight":-0.813}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.","exchange":"NASDAQ","name":"Genelux Corporation","nameEN":"Genelux Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genelux Corporation(GNLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Genelux Corporation(GNLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Genelux Corporation,GNLX,Genelux Corporation股票,Genelux Corporation股票老虎,Genelux Corporation股票老虎国际,Genelux Corporation行情,Genelux Corporation股票行情,Genelux Corporation股价,Genelux Corporation股市,Genelux Corporation股票价格,Genelux Corporation股票交易,Genelux Corporation股票购买,Genelux Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genelux Corporation(GNLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Genelux Corporation(GNLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}